Literature DB >> 32718415

Severe COVID-19 cases with a history of active or latent tuberculosis.

C Liu1, Y Yu2, J Fleming3, T Wang4, S Shen5, Y Wang3, L Fan6, J Ma2, Y Gu7, Y Chen6.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32718415     DOI： 10.5588/ijtld.20.0163

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN： 1027-3719            Impact factor:   2.373


× No keyword cloud information.
  12 in total

Review 1.  The COVID-19 and TB syndemic: the way forward.

Authors:  A Trajman; I Felker; L C Alves; I Coutinho; M Osman; S-A Meehan; U B Singh; Y Schwartz
Journal:  Int J Tuberc Lung Dis       Date:  2022-08-01       Impact factor: 3.427

Review 2.  Pathogenesis of SARS-CoV-2 and Mycobacterium tuberculosis Coinfection.

Authors:  Taif Shah; Zahir Shah; Nafeesa Yasmeen; Zulqarnain Baloch; Xueshan Xia
Journal:  Front Immunol       Date:  2022-06-16       Impact factor: 8.786

3.  Bilateral Foot-Drop Secondary to Axonal Neuropathy in a Tuberculosis Patient With Co-Infection of COVID-19: A Case Report.

Authors:  Mohammad H AlKhateeb; Afia Aziz; Mugahid Eltahir; Abdulnasser Elzouki
Journal:  Cureus       Date:  2020-11-28

Review 4.  COVID-19 and Pediatric Lung Disease: A South African Tertiary Center Experience.

Authors:  Diane M Gray; Mary-Ann Davies; Leah Githinji; Michael Levin; Muntanga Mapani; Zandiswa Nowalaza; Norbertta Washaya; Aamir Yassin; Marco Zampoli; Heather J Zar; Aneesa Vanker
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

5.  Impact of Latent Tuberculosis on Severity and Outcomes in Admitted COVID-19 Patients.

Authors:  Manu Madan; Bhvya Baldwa; Arun Raja; Rahul Tyagi; Tanima Dwivedi; Anant Mohan; Saurabh Mittal; Karan Madan; Vijay Hadda; Pawan Tiwari; Randeep Guleria
Journal:  Cureus       Date:  2021-11-25

Review 6.  The COVID-19/Tuberculosis Syndemic and Potential Antibody Therapy for TB Based on the Lessons Learnt From the Pandemic.

Authors:  Sylvia Annabel Dass; Venugopal Balakrishnan; Norsyahida Arifin; Crystale Siew Ying Lim; Fazlina Nordin; Gee Jun Tye
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

Review 7.  Clinical Characteristics, Diagnosis, Treatment, and Mortality Rate of TB/COVID-19 Coinfectetd Patients: A Systematic Review.

Authors:  Maryam Koupaei; Adel Naimi; Narges Moafi; Paria Mohammadi; Faezeh Sadat Tabatabaei; Soroosh Ghazizadeh; Mohsen Heidary; Saeed Khoshnood
Journal:  Front Med (Lausanne)       Date:  2021-12-01

Review 8.  Mycobacterium tuberculosis and SARS-CoV-2 Coinfections: A Review.

Authors:  Narjess Bostanghadiri; Faramarz Masjedian Jazi; Shabnam Razavi; Lanfranco Fattorini; Davood Darban-Sarokhalil
Journal:  Front Microbiol       Date:  2022-02-03       Impact factor: 5.640

9.  Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).

Authors:  Quan Wang; Shasha Guo; Xiaolin Wei; Quanfang Dong; Ning Xu; Hui Li; Jie Zhao; Qiang Sun
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

10.  Mental health among patients in a COVID-19-dedicated facility.

Authors:  Akhilesh Agarwal; Simran Agrawal; Anup Agarwal
Journal:  Trans R Soc Trop Med Hyg       Date:  2021-01-07       Impact factor: 2.184
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.